Why the study?
Does the FBS predict the presence and extent of subclinical atherosclerosis as accurately as another score in low-risk individuals?
Does the FBS predict the presence and extent of subclinical atherosclerosis as accurately as another score in low-risk individuals?
The FBS is a simpler and more affordable score that predicts subclinical atherosclerosis with similar accuracy to an alternative score in low-risk individuals.
FBS may offer a simpler, affordable option for subclinical atherosclerosis assessment in low-risk patients; leaves open whether it should replace established scores in practice.
Both scores predict the presence and extent of subclinical atherosclerosis with similar accuracy, highlighting the value of the FBS as a simpler and more affordable score for evaluating the risk of subclinical disease.
No takes yet. Share an insight, caveat, or question.
Fernández-Alvira et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: